TABLE 3

Effect of different ABC transport inhibitors on amounts of hesperetin 7-O-glucuronide and hesperetin 7-O-sulfate in the apical and basolateral medium 120 min after addition of 10 μM hesperetin at the apical side of Caco-2 monolayers compared with the control (10 μM hesperetin without inhibitors)

Mean ± S.D. values (n = 4, control n = 7).


Inhibitor

Hesperetin 7-O-Glucuronide

Hesperetin 7-O-Sulfate
Apical
Basolateral
Apical
Basolateral
nmol
Control 1.71 ± 0.44 0.44 ± 0.12 0.25 ± 0.10 0.08 ± 0.05
MK571
    2.4 μM 1.68 ± 0.42 0.41 ± 0.09 0.27 ± 0.06 0.09 ± 0.05
    24 μM 1.39 ± 0.44 0.46 ± 0.15 0.32 ± 0.06 0.12 ± 0.08
CsA
    10 μM 1.66 ± 0.43 0.53 ± 0.12 0.29 ± 0.09 0.11 ± 0.06
PSC-833
    5 μM 1.70 ± 0.31 0.48 ± 0.10 0.32 ± 0.09 0.09 ± 0.05
GF120918
    1 μM 1.39 ± 0.28 0.71 ± 0.17* 0.17 ± 0.03 0.10 ± 0.04
    5 μM 1.11 ± 0.25* 0.85 ± 0.30* 0.16 ± 0.03 0.14 ± 0.08
    10 μM 1.09 ± 0.34* 0.88 ± 0.17*** 0.14 ± 0.05 0.14 ± 0.09
Ko143
    1 μM 1.50 ± 0.23 0.82 ± 0.12*** 0.23 ± 0.05 0.16 ± 0.04*
    2 μM 0.89 ± 0.31** 1.14 ± 0.40** 0.14 ± 0.06 0.25 ± 0.11**
    5 μM
0.96 ± 0.13**
1.34 ± 0.18***
0.10 ± 0.04*
0.26 ± 0.09**
  • * p < 0.05, significantly different compared with the control.

  • ** p < 0.01, significantly different compared with the control.

  • *** p < 0.001, significantly different compared with the control.